Oraverse

From WikiMD's Wellness Encyclopedia

What is Oraverse?[edit | edit source]

Phentolamine
Phentolamine Structural Formulae



What are the uses of this medicine?[edit | edit source]

  • Oraverse (Phentolamine mesylate) is used for adult and pediatric patients ages 3 years and older for the reversal of soft-tissue anesthesia, i.e., anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic containing a vasoconstrictor.


How does this medicine work?[edit | edit source]

  • Phentolamine mesylate, the active ingredient in OraVerse, produces an alpha-adrenergic block of relatively short duration resulting in vasodilatation when applied to vascular smooth muscle.


Who Should Not Use this medicine ?[edit | edit source]

This medicine cannot be used in patients with:

  • Hypersensitivity to the active substance or to any ingredients in the formulation.


What drug interactions can this medicine cause?[edit | edit source]

  • There are no known drug interactions with OraVerse.


Is this medicine FDA approved?[edit | edit source]

  • Initial U.S. Approval: 1952


How should this medicine be used?[edit | edit source]

Recommended dosage:

  • The recommended dose of OraVerse is based on the number of cartridges of local anesthetic with vasoconstrictor administered:
Amount of Local Anesthetic Administered Dose of OraVerse [mg] Dose of OraVerse [Cartridge(s)]
1/4 Cartridge 0.1 1/4
½ Cartridge 0.2 ½
1 Cartridge 0.4 1
2 Cartridges 0.8 2


Administration:

  • OraVerse is administered using the same location(s) and same technique(s) (infiltration or block injection) used for the administration of local anesthetic.


What are the dosage forms and brand names of this medicine?[edit | edit source]

This medicine is available in fallowing doasage form:

  • As 0.4 mg/1.7 mL solution per cartridge

This medicine is available in fallowing brand namesː

  • OraVerse


What side effects can this medication cause?[edit | edit source]

The most common side effects of this medicine include:

  • injection-site pain


What special precautions should I follow?[edit | edit source]


What to do in case of emergency/overdose?[edit | edit source]

Symptoms of overdosage may include:

Treatment of overdosage:

  • There is no specific antidote; treatment consists of appropriate monitoring and supportive care.
  • Substantial decreases in blood pressure or other evidence of shock-like conditions should be treated vigorously and promptly.


Can this medicine be used in pregnancy?[edit | edit source]

  • There are no available data with OraVerse in pregnant women to inform a drug-associated risk for major birth defects and miscarriage.


Can this medicine be used in children?[edit | edit source]

  • The safety and efficacy of OraVerse has not been established in patients younger than 3 years.


What are the active and inactive ingredients in this medicine?[edit | edit source]

Active ingredient:

  • Phentolamine Mesylate

Inactive ingredients:

  • Edetate Disodium
  • Mannitol
  • Sodium Acetate
  • Water
  • Acetic Acid
  • Sodium Hydroxide
  • Nitrogen


Who manufactures and distributes this medicine?[edit | edit source]

Manufactured by: Novocol Pharmaceutical of Canada, Inc. Cambridge, Ontario, Canada

Manufactured for:

  • Septodont, Inc
  • Louisville, CO


What should I know about storage and disposal of this medication?[edit | edit source]

  • Store at controlled room temperature, 20-25°C (68-77°F) with brief excursions permitted between 15-30°C (59-86°F).
  • Protect from direct heat and light.
  • Do not permit to freeze.


Oraverse Resources